Breaking News

C2 PHARMA Granted DMF Approval for Pilocarpine Nitrate

Pilocarpine Nitrate is an ophthalmic API extracted from the Jaborandi plant and is primarily used for treating glaucoma and diagnostics.

C2 PHARMA,  a company involved in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), reported the approval of a C-DMF for Pilocarpine Nitrate, an API manufactured by its Brazilian partner Anidro do Brasil. Pilocarpine Nitrate is an ophthalmic API extracted from the Jaborandi plant and is primarily used for treating glaucoma and other specific diagnostic applications. C2 PHARMA the main supporter of the “Partnership for a Better World” initia...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters